Medtronic

25 Years of Innovation. Research. Support.

Watch the video

DBS THERAPY OFF/ON DEMO
See how DBS Therapy has improved Gary's life.

DBS THERAPY OFF/ON DEMO

See how DBS Therapy has improved Gary's life.
More information (see more)Less information (see less)


Innovation

devices

For more than 25 years, together we have delivered meaningful innovation.

  • Broadest portfolio including Activa neurostimulators: primary cell or rechargeable devices for unilateral or bilateral stimulation.
  • The most indications for DBS Therapy including Parkinson's Disease, essential tremor, dystonia*, and OCD*
  • First, and only full-body MR Conditional DBS Systems **

Research

DBS showed a statistically significant improvement of 26% in PD related quality of life vs. 1% worsening in patients receiving best medical therapy (BMT) alone (as measured by the Parkinson's Disease Questionnaire. PDQ-39 Summary Index).1,2

graph

To learn more about our decades of research, see our evidence compendium.


Support

The Medtronic DBS difference is giving you support at every step.

The Medtronic DBS difference is giving you support at every step. We offer comprehensive resources, training, and support including medical education, and pre- and post- op patient support. 

We also offer your patients 24/7 global support through the Support LinkSM program.


 

*Humanitarian Device: Authorized by Federal Law to aid in the management of chronic, intractable (drug refractory) primary dystonia, including generalized and/or segmental dystonia, hemidystonia, and cervical dystonia (torticollis), in patients seven years of age or above. The effectiveness of the devices for treating these conditions has not been demonstrated. Learn more about HDE.
*Humanitarian Device: Authorized by Federal (U.S.A.) law for use as an adjunct to medications and as an alternative to anterior capsulotomy for treatment of chronic, severe, treatment-resistant obsessive-compulsive disorder (OCD) in adult patients who have failed at least three selective serotonin reuptake inhibitors (SSRIs). The effectiveness of this device for this use has not been demonstrated. Learn more about HDE.
**Medtronic DBS systems are MR Conditional and safe in the MR environment as long as certain conditions are met. If the conditions are not met, a significant risk is tissue lesions from component heating, especially at the lead electrodes, resulting in serious and permanent injury including coma, paralysis, or death. Refer to MRI Important Safety Information for a complete list of conditions and instructions for use.

 

References:
1. Schuepbach WMM, Rau J, Knudsen K, et al. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med. February 14, 2013;368:610-22.
2. Medtronic DBS Therapy for Parkinson’s Disease and Essential Tremor Clinical Summary, November 1, 2015. 

UC201706125 EN